Docoh
Loading...

IART Integra Lifesciences

Integra LifeSciences Holdings Corp. engages in the manufacture and sale of medical instruments, devices, and equipment. It operates through the Codman Specialty Surgical, and Orthopedics and Tissue Technologies segments. The Codman Specialty Surgical segment refers to the company's neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and precision tools and instruments business, which sells instrument patterns and surgical and lighting products to hospitals, surgery centers, and dental, podiatry, and veterinary offices. The Orthopedics and Tissue Technologies segment includes offerings such as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.

Company profile

Ticker
IART
Exchange
CEO
Peter Arduini
Employees
Incorporated
Location
Fiscal year end
Former names
INTEGRA LIFESCIENCES CORP
SEC CIK
IRS number
510317849

IART stock data

(
)

Calendar

23 Feb 21
18 Apr 21
31 Dec 21
Quarter (USD)
Dec 20 Sep 20 Jun 20 Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
14 Apr 21 Evoli Lisa Common Stock Sell Dispose S No Yes 70 1,785 124.95K 7,825
14 Apr 21 Evoli Lisa Common Stock Option exercise Aquire M No Yes 43.68 1,785 77.97K 9,610
14 Apr 21 Evoli Lisa Common Stock Sell Dispose S No Yes 70 3,440 240.8K 7,825
14 Apr 21 Evoli Lisa Common Stock Option exercise Aquire M No Yes 56.23 3,440 193.43K 11,265
14 Apr 21 Evoli Lisa Common Stock Sell Dispose S No Yes 70 1,081 75.67K 7,825
14 Apr 21 Evoli Lisa NQSO Common Stock Option exercise Dispose M No Yes 56.23 3,440 193.43K 1,147
14 Apr 21 Evoli Lisa NQSO Common Stock Option exercise Dispose M No Yes 43.68 1,785 77.97K 0
14 Apr 21 Coleman Glenn Common Stock Sell Dispose S No Yes 70.5 4,002 282.14K 32,056
9 Apr 21 Coleman Glenn Common Stock Sell Dispose S No Yes 70 12,500 875K 36,058
9 Apr 21 Coleman Glenn Common Stock Option exercise Aquire M No Yes 19.41 12,500 242.63K 48,558

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

99.4% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 253 235 +7.7%
Opened positions 33 22 +50.0%
Closed positions 15 49 -69.4%
Increased positions 82 83 -1.2%
Reduced positions 92 84 +9.5%
13F shares
Current Prev Q Change
Total value 5.46B 3.4B +60.3%
Total shares 84.03M 72.08M +16.6%
Total puts 33.3K 17.93K +85.7%
Total calls 37.1K 26K +42.7%
Total put/call ratio 0.9 0.7 +30.1%
Largest owners
Shares Value Change
Tru St Partnership 9.89M $642.14M NEW
Wellington Management 9.26M $601.38M +18.4%
Capital Research Global Investors 8.24M $534.77M -8.1%
Vanguard 6.47M $420.33M +1.5%
Champlain Investment Partners 6.46M $419.28M +3.0%
BLK Blackrock 6.42M $416.98M +0.2%
JHG Janus Henderson 4.62M $300.07M +14.1%
Cooke & Bieler 2.71M $175.98M +9.9%
Clearbridge Advisors 2.57M $166.56M -0.7%
Eaton Vance Management 2.49M $161.48M +46.8%
Largest transactions
Shares Bought/sold Change
Tru St Partnership 9.89M +9.89M NEW
Wellington Management 9.26M +1.44M +18.4%
Eaton Vance Management 2.49M +792.59K +46.8%
Capital Research Global Investors 8.24M -722.3K -8.1%
Norges Bank 713.23K +713.23K NEW
JHG Janus Henderson 4.62M +572.29K +14.1%
Brown Advisory 19.81K -453.95K -95.8%
FMR 342.37K -292.63K -46.1%
Endurant Capital Management 0 -281.61K EXIT
Cooke & Bieler 2.71M +244.5K +9.9%

Financial report summary

?
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: adequacy, Algicell, Allograft, amortizable, Appendix, Aquasonic, attached, Auragen, Bactiseal, benign, Bicol, Bilayer, BioBlock, Brainet, breaking, burdensome, Businesswomen, CAD, cancellation, CCPA, CereLink, certainty, climate, closure, confident, consecutive, content, contractor, Council, COVID, Cranioplastic, CSS, Cterm, curtail, curtailed, defray, depression, devalue, discourage, discretionary, earlier, ease, Edge, elevate, elevated, embedded, Endorelease, escalate, faster, feature, female, fight, freeze, frequency, gas, Gender, geopolitical, goal, greenhouse, Hakim, halting, handpiece, hemorrhage, hereof, Hermetic, hired, hiring, Holter, home, IBWM, includedin, intracerebral, irrevocably, journal, JPY, Katalyst, Latin, Learning, lifecycle, MA, male, malignant, medium, mentoring, mentorship, Microsensor, mid, midst, Mischler, MoniTorr, NaNne, Nicolet, official, onset, OTT, outsourced, overtime, pandemic, payer, persist, population, porcine, postponement, Pound, prioritize, prolonged, Pureflow, reap, recession, recruiting, recruitment, redeemed, redemption, referenced, reinforce, relief, renegotiate, reprioritization, reputation, resection, resiliency, retention, Revize, role, school, seizure, shelter, showed, showing, Signacreme, situation, slight, Society, speed, Spider, Spin, sponsorship, stay, Sterling, strain, subcontracted, subtle, suggested, suite, surface, swiftly, talent, talented, timeframe, TN, travel, Treasurer, trial, Ultra, unpaid, unprecedented, USD, vaccine, vitro, voluntarily, voluntary, VPV, wealth, women, workplace, Write, wrote, zRIP
Removed: abide, accept, acquiring, adhere, agree, amend, analyzed, APACMed, ASA, assume, attribute, Austria, bargaining, Bulletin, bundled, Cadence, Camino, carbon, challenged, CHIP, collaboratively, collective, community, complying, conclude, conditioned, Confluent, considerable, continual, correct, Correspondingly, costlier, defund, deploy, deposit, deposited, detecting, dilution, distracting, divest, East, elbow, enforceable, engineering, erosion, excise, facilitate, FDARA, FDCA, focusing, formula, fraudulent, functioning, GILTI, grown, Hallu, headcount, hereto, HSBC, hurricane, implant, incompatibility, ineffective, inheriting, inpatient, instructed, insured, intention, intervening, introduced, Italy, joined, justified, kind, knee, leg, MACRA, malfunction, mandate, Maria, MDR, MDUFA, Mecomed, MedTech, merge, Mexico, Middle, monitored, negotiating, nonconformance, notable, noted, notify, offloading, owner, Pakistan, passed, pathway, penalty, pending, Pennsylvania, placement, poor, pose, positioned, preliminary, presence, promulgate, publicity, pyrolytic, QPP, reauthorization, reauthorized, reclassification, recurring, referendum, refinance, remeasurement, removed, remuneration, repatriated, repealed, replaced, replacing, representation, restrain, revaluation, revocation, revolver, rheumatoid, rigorously, scrutinize, shared, shift, Spain, step, submission, suddenly, suntrust, Supreme, surgeon, surveillance, suspension, taxed, terrorism, Titan, transitional, transitioning, Trump, UDI, UFJ, uncovering, unreasonable, unrest, user, validation, vascular, warehouse, weight, widely, Wright, XT

Patents